Telexos GmbH

Telexos is a Cancer Diagnostics Startup providing services for cancer institutions and cancer companies based on its new highly sensitive liquid biopsy based technology. This technology allows quantitative detection of drug targets (protein level) as well as detection of resistances (DNA) and more. Therefore, the technology can be used for a variety of applications like e.g., early detection of cancer, patient stratification and therapy monitoring. Telexo also develops products fort eh cnacer research and cancer diagnostics market.